EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TBAJ-587, a novel diarylquinoline, is active against Mycobacterium abscessus

Junsheng Fan iD, Zhili Tan, Siyuan He, Anqi Li, Yaping Jia, Juan Li, Zhemin Zhang, Bing Li iD, Haiqing Chu iD

Antimicrobial Agents and Chemotherapy · 05.12.2024 · 68 (12)

DOI: 10.1128/aac.00945-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.12.2024. Verfasst von Junsheng Fan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Diarylquinolines, Microbial Sensitivity Tests, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), STCSM | Natural Science Foundation of Shanghai Municipality (), STCSM | Science and Technology Innovation Plan Of Shanghai Science and Technology Commission ().

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nontuberculous mycobacteria (NTM) infections are extremely difficult to treat due to a natural resistance to many antimicrobials. TBAJ-587 is a novel diarylquinoline, which shows higher anti-tuberculosis activity, lower lipophilicity, and weaker inhibition of hERG channels than bedaquiline (BDQ). The susceptibilities of 11 NTM reference strains and 194 clinical Mycobacterium abscessus isolates to TBAJ-587 were determined by the broth microdilution assay. The activity of TBAJ-587 toward the growth of M. abscessus in macrophages was also evaluated. Minimum bactericidal concentration and time-kill kinetic assays were conducted to distinguish between the bactericidal and bacteriostatic activities of TBAJ-587. The synergy between TBAJ-587 and eight clinically important antibiotics was determined using a checkerboard assay. TBAJ-587 was highly effective against M. abscessus by targeting its F-ATP synthase c chain. The antimicrobial activities of TBAJ-587 and BDQ toward intracellular M. abscessus were comparable. The in vivo activities of TBAJ-587 and BDQ in an immunocompromised mouse model were also comparable. TBAJ-587 expressed bactericidal activity and was compatible with eight anti-NTM drugs commonly used in clinical practice; no antagonism was discovered. As such, TBAJ-587 represents a potential candidate for the treatment of NTM infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium abscessusDiarylquinolinesMicrobial Sensitivity TestsMycobacterium Infections, NontuberculousAnimalsMiceHumansMacrophagesAnti-Bacterial AgentsAntitubercular AgentsQuinolinesDrug Synergism

Stichwörter der Autor:innen

Mycobacterium abscessusTBAJ-587diarylquinolinenontuberculous mycobacteria

Substanzen

DiarylquinolinesbedaquilineAnti-Bacterial AgentsAntitubercular AgentsQuinolines

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • School of Medicine, Tongji University, Shanghai, China.
  • Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Junsheng Fan, Bing Li, Haiqing Chu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • STCSM | Natural Science Foundation of Shanghai Municipality ()
  • STCSM | Science and Technology Innovation Plan Of Shanghai Science and Technology Commission ()
  • Clinical Research foundation of Shanghai Pulmonary Hospital

Zitieren

APA

Fan, J., Tan, Z., He, S., Li, A., Jia, Y., Li, J., Zhang, Z., Li, B., & Chu, H. (2024). TBAJ-587, a novel diarylquinoline, is active against Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy, 68(12). https://doi.org/10.1128/aac.00945-24

Vancouver

Fan J, Tan Z, He S, Li A, Jia Y, Li J, et al. TBAJ-587, a novel diarylquinoline, is active against Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. 2024;68(12). doi:10.1128/aac.00945-24

BibTeX
@article{Fan2024,
  author = {Fan, Junsheng and Tan, Zhili and He, Siyuan and Li, Anqi and Jia, Yaping and Li, Juan and Zhang, Zhemin and Li, Bing and Chu, Haiqing},
  title = {TBAJ-587, a novel diarylquinoline, is active against Mycobacterium abscessus},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  volume = {68},
  number = {12},
  doi = {10.1128/aac.00945-24}
}
Kostenlos starten →